The integration of genomic profiling and precision oncology into Australia’s cancer care system could transform our approach to one of the nation’s leading causes of death.

In a world-first, Monash University is leading a DNA screening program that will allow Australians aged 18-40 to assess their risk of cancer and heart disease. It is thought that early detection of these diseases will allow young Australians to make more informed health decisions.

Hunting for cancer of unknown primary — the cancer that hides its face discusses the difficulty in treating patients with cancers that have an unknown origin and how a study is…

If you have cancer, is genomics right for you? 4 things every patient should know describes the positives and negatives of having genomic testing to help guide cancer treatment. Please…

Genomics provide hope for those with ‘one in a million’ cancer diagnosis describes how genomic testing may be able to improve diagnosis and treatment for patients with rare cancers, who usually…

‘Cutting-edge’ DNA test for Queensland blood cancer patients describes how genomic sequencing may be used to guide treatment for patients with blood cancer by determining which genetic change(s) are causing their…

Rare Solutions: A Time to Act was launched at the Rare Cancers Australia (RCA) Canberra Forum on 9th August. The report has been developed by RCA to address the challenges…